Groupe Athena, Inc. announced recently that it will post its financial results, and as shown by the records released today, the company had 15% improvement over its previous report.
The annual revenue of Groupe Athena, Inc. has an increase of over 15% compared to its fiscal year’s previous record ($65,189,762). The record exhibits the company’s 5th consecutive double digit growth in annual returns. EBITDA results ($10,938,698) have also been included in the financial statement and net after tax income ($0.14 a share, $6,501,645). Strength of Groupe Athena, Inc.’s assets has also been drawn ($14,988,476) and the company’s total assets except for its liabilities ($0.47 per common share, $22,196,645).
D. Purohit, Groupe Athena, Inc.’s Chairman, expressed his gladness towards the strong expansion path being taken by the management. According to him, developing new strategies will be open as finances are sustained as necessary. For many years to come, the chairman uttered his outlook of a dynamic Groupe Athena, Inc. as driven by the organization’s research and development labors.
Group Athena Inc. began operating on July 1, 2008. It aids India and Southeast Asia companies in getting regulatory approvals from authentic bodies of United States. Groupe Athena, Inc. also assists in exporting pharmaceutical products and medical devices of the companies it serves.